Hematologic Cancers Archives - Page 3 of 11 - Together4Cancer Compass

Patients

HCPs

Home

Categories

Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

Post category:Hematologic Cancers
Reading time:1 min read

This scoping review systematically examined the safety and feasibility of combining immune checkpoint inhibitors (ICIs)...

Continue Reading

An Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.

Post category:Hematologic Cancers
Reading time:1 min read

This study addresses a key limitation in CRISPR/Cas9 gene knockout research within cancer immunology, where persistent e...

Continue Reading

A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Post category:Hematologic Cancers
Reading time:1 min read

This retrospective cohort study of 6,526 adult cancer patients treated with immune checkpoint inhibitors (ICIs) between...

Continue Reading

Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

Post category:Hematologic Cancers
Reading time:1 min read

This multicenter retrospective study evaluated talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, in 114 heav...

Continue Reading

Regulation of RNA-binding proteins by small biomolecules.

Post category:Hematologic Cancers
Reading time:1 min read

This publication reviews the critical role of RNA-binding proteins (RBPs) in post-transcriptional gene regulation, inclu...

Continue Reading

The Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC-ONC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method.

Post category:Hematologic Cancers
Reading time:1 min read

This publication addresses the critical importance of safe and reliable venous access in cancer care, recognizing the ne...

Continue Reading